Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104371010B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104371010B details a safer Fmoc solid-phase synthesis for Ganirelix. This method improves yield and purity while eliminating toxic HF usage for reliable supply.